The mammalian EGFR and components of the mammalian EGF signaling pathway are known to enhance glucose absorption in the gut [128], induce obesity in ovariectomized [129] and aged female mice [130], are decreased in adipose tissues of calorie restricted mice [131], and are associated with hyperglycemia in humans [132]. Here, EGFR is linked to obesity disorder.